Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2014; 20(10): 2492-2498
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2492
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2492
Table 2 Placebo-controlled studies: side effects of melatonin in irritable bowel syndrome patients
Ref. | Subjects (total, age, IBS criteria) | Dosage, frequency, duration | Sleepiness | GI side effect | Others |
Lu et al[26], 2005, Singapore | 17, 41+/-14 years old woman, ROME II IBS | 3 mg bedtime for 8 wk | 1 × Daytime sleepiness (both treatment and placebo group) | Nil | Nil |
Saha et al[27], 2007, India | 18, 18-65 years old, ROME II IBS | 3 mg bedtime for 8 wk | 1 × Drowsiness (both groups), | Nil | 1 decreased libido |
Chojnacki et al[72], 2013, Poland | 80, 48-65 years old woman, ROME III IBS | 3 mg morning, 5 mg bedtime for 6 mo | Nil | Nil | 2 fatigue, 1 vertigo |
- Citation: Siah KTH, Wong RKM, Ho KY. Melatonin for the treatment of irritable bowel syndrome. World J Gastroenterol 2014; 20(10): 2492-2498
- URL: https://www.wjgnet.com/1007-9327/full/v20/i10/2492.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i10.2492